This site looks better in landscape mode
Skip to content
AKL Therapeutics
Radically improving healthspan with a novel multifactorial approach to osteoarthritis
Developing a novel therapeutic for inflammatory diseases with a high unmet need
Developing a novel therapeutic for inflammatory diseases with a high unmet need
>650M
Knee osteoarthritis affects more than 654M people worldwide
